MENU
+Compare
CLNN
Stock ticker: NASDAQ
AS OF
Jul 3, 02:00 PM (EDT)
Price
$3.90
Change
-$0.05 (-1.27%)
Capitalization
35.03M

CLNN Clene Inc. Forecast, Technical & Fundamental Analysis

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics... Show more

CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLNN with price predictions
Jul 02, 2025

CLNN's Indicator enters downward trend

The Aroon Indicator for CLNN entered a downward trend on May 30, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 211 similar instances where the Aroon Indicator formed such a pattern. In of the 211 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CLNN moved out of overbought territory on June 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CLNN as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CLNN turned negative on June 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLNN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 71 cases where CLNN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

CLNN moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CLNN crossed bullishly above the 50-day moving average on June 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLNN advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLNN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLNN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.025) is normal, around the industry mean (16.522). P/E Ratio (0.000) is within average values for comparable stocks, (58.479). CLNN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (84.034) is also within normal values, averaging (261.553).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLNN is expected to report earnings to fall 14.78% to -7 cents per share on August 12

Clene Inc. CLNN Stock Earnings Reports
Q2'24
Est.
$-0.08
Q1'25
Missed
by $0.02
Q4'24
Missed
by $1.54
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.06
The last earnings report on May 07 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 28.56K shares outstanding, the current market capitalization sits at 35.03M.
A.I. Advisor
published General Information

General Information

a blank check company, which was created with purpose to acquire, engage in a share exchange, share reconstruct, amalgate, and purchase all substantially all of the assets of, entering into contractual arrangements

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
6550 South Millrock Drive
Phone
+1 801 676-9695
Employees
85
Web
https://www.clene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CADE34.680.67
+1.97%
Cadence Bank
ALEX18.180.17
+0.94%
Alexander & Baldwin
ITW258.502.05
+0.80%
Illinois Tool Works
LVTX1.320.01
+0.76%
LAVA Therapeutics NV
HOFT11.520.04
+0.35%
Hooker Furnishings Corp

CLNN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with LYRA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
+1.28%
LYRA - CLNN
38%
Loosely correlated
+3.71%
VERA - CLNN
34%
Loosely correlated
+2.83%
KZIA - CLNN
33%
Poorly correlated
-0.75%
BPMC - CLNN
31%
Poorly correlated
-0.10%
GOSS - CLNN
30%
Poorly correlated
-3.60%
More